TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: “ABPI”), today announced that Biovest is scheduled to present at 19th International Molecular Med Tri-Con Cancer Biologics Conference to be held February 19–23 at the Moscone Convention Center in San Francisco.
